Dethlefs Sven
- SEC CIK
- 0001726010
No open-market purchases or sales filed in the past year.
Current role at each company
- TEVA Teva Pharmaceutical Industries LtdEVP, North America Commercialas of Mar 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dethlefs Sven as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 (view filing) | Mar 6-7 | 2 days | Dethlefs SvenEVP, North America Commercial | SSale | −77.4K | $9.55 | −$739.8K | −31.9%165.4K after | 2 lots |
| Mar 2, 2023 (view filing) | Feb 28 | 2 days | Dethlefs SvenEVP, North America Commercial | SSale | −59.7K | $9.89 | −$590.0K | −26.5%165.4K after | 2 lots |
| Mar 8, 2022 (view filing) | Mar 4-7 | 4 days | Dethlefs SvenEVP, North America Commercial | SSale | −10.9K | $7.41 | −$80.7K | −6.2%165.4K after | 2 lots |
| Mar 2, 2022 (view filing) | Feb 28 | 2 days | Dethlefs SvenEVP, North America Commercial | SSale | −4.86K | $8.14 | −$39.6K | −4.7%99.5K after | |
| Feb 10, 2022 (view filing) | Feb 9 | 1 day | Dethlefs SvenEVP, North America Commercial | SSale | −4.14K | $9.06 | −$37.5K | −4.5%87.0K after |